AUGMENTIN '500'
AMOXICILLIN; CLAVULANATE POTASSIUM
Approval overview AUGMENTIN '500' is listed in Drugs@FDA under application 050564 (NDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient AMOXICILLIN; CLAVULANATE POTASSIUM Form and strength TABLET;ORAL - 500MG;EQ 125MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor US ANTIBIOTICS Submission history Latest submission status date: 2024-05-01 00:00:00.
Structured Monograph
Clinical summary
Approval overview AUGMENTIN '500' is listed in Drugs@FDA under application 050564 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient AMOXICILLIN; CLAVULANATE POTASSIUM Form and strength TABLET;ORAL - 500MG;EQ 125MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor US ANTIBIOTICS Submission history Latest submission status date: 2024-05-01 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.